Sign up now and fund within 24h to get free NKE, GPRO or DBX stock. T&Cs apply.
Redeem Now

Neurocrine Biosciences Inc.

1 day chart

Kickstart your portfolio with a U.S. stock on us

Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.

Sign up and fund a new Wall St account and get a full U.S. share.

T&Cs apply
Claim now
Kickstart your portfolio with a U.S. stock on us

About NBIX

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. The Company is engaged in discovering and developing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. Its diverse portfolio includes the United States Food and Drug Administration-approved treatments for tardive dyskinesia, chorea associated with Huntington’s disease, endometriosis and uterine fibroids, as well as a robust pipeline, including multiple compounds in mid-to late-phase clinical development across its core therapeutic areas. Its commercial products include INGREZZA, ALKINDI, EFMODY, Orilissa and Oriahnn. INGREZZA is marketed as DYSVAL (valbenazine) in Japan and REMLEAS (valbenazine) in other select Asian markets, where Mitsubishi Tanabe Pharma Corporation retains commercialization rights. ALKINDI is marketed as ALKINDI SPRINKLE (hydrocortisone) in the United States, where Eton Pharmaceuticals, Inc. retains commercialization rights.

Buy US stocks in Australia starting with NBIX. Open an account and start investing today!

Market Capitalisation

$11.95B

Price-earnings ratio

-

Dividend yield

0.00%

Volume

728.02K

High today

$119.07

Low today

$118.03

Open price

$118.73

52-week high

$157.98

52-week low

$103.63

Ready to start your investing journey with Stake?

Open an account

NBIX FAQs

  1. Find the right investing platform for you. To buy NBIX shares in Australia, you’ll need to open an account with an investing platform that offers the security. Try Stake, you can sign up in minutes.
  2. Fund your brokerage account. Once you are set up you can deposit into your account with different payment methods.
  3. Search for NBIX or Neurocrine Biosciences Inc.. Find the stock by using the search function and go to the NBIX page.
  4. Place an order to buy NBIX. Press the ‘Buy’ button and choose an order type to place your trade. Depending on the order type, the trade will go through straight away or when a price target is hit.
  5. Monitor your portfolio. You’ve now purchased some NBIX shares. Stay on top of your portfolio and monitor its performance. You may be eligible for dividends and shareholder voting rights that affect your stock.

The ticker symbol for Neurocrine Biosciences Inc. is NBIX.

One share of NBIX is valued at $118.67 as of 18 October 2024.

As of 18 October 2024 Neurocrine Biosciences Inc. has a market cap of $11.95B.

The Price to Earnings ratio of NBIX is 35.74.

The Earnings Per Share of NBIX is $3.31.

The Neurocrine Biosciences Inc. 52-week high stock price is $157.98.

The Neurocrine Biosciences Inc. 52-week low stock price is $103.63.

Yes, the Stake investing platform allows you to buy NBIX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in NBIX
on Stake

Buy NBIX from US$3 brokerage

Invest in 9,500+ U.S. stocks and ETFs

Own a slice of NBIX from only US$10 with fractional shares

Get started
Canstar award phone
NBIX related stocks

Stake logo
Over 7,000 5-star reviews
App Store logoGoogle Play logo

Subscribe to our free newsletters

By subscribing, you agree to our Privacy Policy.

Stakeshop Pty Ltd, trading as Stake, ACN 610105505, is an authorised representative (Authorised Representative No. 1241398) of Stakeshop AFSL Pty Ltd (Australian Financial Services Licence no. 548196). Stake SMSF Pty Ltd (‘Stake Super’) is not licensed to provide financial product advice under the Corporations Act. This specifically applies to any financial products which are established if you instruct Stake Super to set up a self managed super fund (‘SMSF’). When you sign up to Stake Super, you are contracting with Stake SMSF Pty Ltd who will assist in the establishment of a SMSF under a ‘no advice model’. You will also be referred to Stakeshop Pty Ltd to enable your trading account and bank account to be set up in order to use the Stake Website and/or App. For more information about SMSFs, see our SMSF Risks page. The information on our website or our mobile application is not intended to be an inducement, offer or solicitation to anyone in any jurisdiction in which Stake is not regulated or able to market its services. At Stake and Stake Super, we’re focused on giving you a better investing experience but we don’t take into account your personal objectives, circumstances or financial needs. Any advice given by Stake is of a general nature only. As investments carry risk, before making any investment decision, please consider if it’s right for you and seek appropriate taxation and legal advice. Please view our Financial Services GuideTerms & ConditionsPrivacy Policy and Disclaimers before deciding to invest on or use Stake or Stake Super. By using our website or service in any way, you agree to our Privacy Policy and Terms & Conditions. All financial products involve risk and you should ensure you understand the risks involved as certain financial products may not be suitable to everyone. Past performance of any product described on this website is not a reliable indication of future performance. Stake and Stake Super are registered trademarks in Australia.

Copyright © 2024 Stake. All rights reserved.